Remy Durand, PhD
Dr. Remy Durand joins Alpine BioVentures with over 10 years of experience in life sciences research, consulting, and investing.
Prior to Alpine BioVentures, Dr. Durand was a Vice President on the life sciences investment team at Frazier Healthcare Partners, one of the first dedicated healthcare investment firms. During his time at Frazier, he was a board observer or director on multiple investments including Alpine Immune Sciences (NASDAQ: ALPN), Aptinyx (NASDAQ: APTX), and Scout Bio. Earlier in his career, he was an investment professional at GE Ventures Healthcare and spent time as a management consultant with LEK Consulting, a premier strategic advisor to the life sciences industry. Dr. Durand is also currently the Vice President of Business Development at Alpine BioVentures portfolio company Alpine Immune Sciences (NASDAQ: ALPN).
Dr. Durand received his Ph.D. in Bioengineering from Stanford University, where he was a National Science Foundation Graduate Research Fellow. Dr. Durand’s doctoral research used optogenetics to map neural circuits and to understand the physiologic basis of functional neural imaging, which resulted in publications in Nature and Nature Protocols. He also holds a B.S.E. in Biomedical Engineering from Case Western Reserve University.